flutamide and testolactone

flutamide has been researched along with testolactone in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Barnes, KM; Cutler, GB; Hill, S; Jones, JV; Laue, L; Merke, DP	1
Cutler, GB; Merke, DP	1
Cutler, GB; Fields, J; Hill, S; Jones, JV; Keil, MF; Merke, DP	1
Calis, KA; Charmandari, E; Keil, MF; Merke, DP; Mohassel, MR; Remaley, A	1

Trials

2 trial(s) available for flutamide and testolactone

Article	Year
A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:10 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Bone Development; Child; Child, Preschool; Dehydroepiandrosterone; Female; Flutamide; Humans; Hydrocortisone; Infant; Male; Seasons; Testolactone; Weight Gain	1996
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:3 Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Development; Child; Child, Preschool; Female; Flutamide; Follow-Up Studies; Growth; Hormones; Humans; Hydrocortisone; Male; Testolactone; Weight Gain	2000

Article

Year

A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.

The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:10

Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Bone Development; Child; Child, Preschool; Dehydroepiandrosterone; Female; Flutamide; Humans; Hydrocortisone; Infant; Male; Seasons; Testolactone; Weight Gain

1996

Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.

The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:3

Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Bone Development; Child; Child, Preschool; Female; Flutamide; Follow-Up Studies; Growth; Hormones; Humans; Hydrocortisone; Male; Testolactone; Weight Gain

2000

Other Studies

3 other study(ies) available for flutamide and testolactone

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
New approaches to the treatment of congenital adrenal hyperplasia. JAMA, 1997, Apr-02, Volume: 277, Issue:13 Topics: Adrenal Hyperplasia, Congenital; Age Determination by Skeleton; Androgen Antagonists; Child; Cyproterone; Drug Therapy, Combination; Female; Fludrocortisone; Flutamide; Growth; Humans; Hydrocortisone; Mineralocorticoid Receptor Antagonists; Spironolactone; Testolactone	1997
Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:7 Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Child; Cortisone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Flutamide; Humans; Hydrocortisone; Male; Metabolism, Inborn Errors; Testolactone	2002